neurobion advance 100 mg + 50 mg + 1 mg tabletki powlekane
p&g health germany gmbh - thiamini nitras + pyridoxini hydrochloridum + cyanocobalaminum - tabletki powlekane - 100 mg + 50 mg + 1 mg
fluconazole hasco 5 mg/ml syrop
przedsiębiorstwo produkcji farmaceutycznej hasco-lek s.a. - fluconazolum - syrop - 5 mg/ml
fexofenadine hydrochloride cipla 120 mg tabletki powlekane
cipla europe nv - fexofenadini hydrochloridum - tabletki powlekane - 120 mg
fexofenadine hydrochloride cipla 180 mg tabletki powlekane
cipla europe nv - fexofenadini hydrochloridum - tabletki powlekane - 180 mg
zoledronic acid teva pharma
teva b.v. - kwas zoledronowy - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - leki stosowane w leczeniu chorób kości - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture including those with a recent low-trauma hip fracture. treatment of osteoporosis associated with long-term systemic glucocorticoid therapy: , in post-menopausal women;, in men; , at increased risk of fracture. leczenie choroby pageta kości u dorosłych.
ezetimibe genoptim 10 mg tabletki
synoptis pharma sp. z o.o. - ezetimibum - tabletki - 10 mg
micafungin zentiva 50 mg proszek do sporządzania koncentratu roztworu do infuzji
zentiva, k.s. - micafunginum - proszek do sporządzania koncentratu roztworu do infuzji - 50 mg
micafungin zentiva 100 mg proszek do sporządzania koncentratu roztworu do infuzji
zentiva, k.s. - micafunginum - proszek do sporządzania koncentratu roztworu do infuzji - 100 mg
teriparatide sun
sun pharmaceutical industries europe b.v. - teryparatyd - osteoporosis; osteoporosis, postmenopausal - wapń homeostaza - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.
kauliv
strides pharma (cyprus) limited - teryparatyd - osteoporosis; osteoporosis, postmenopausal - wapń homeostaza - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.